SCHEMBL21775601

SCHEMBL21775601

Cc1nc2cc(-c3ccccc3)nn2c(N2CCCC(C)(C(=O)O)C2)c1C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 7/20 0.46
HPGD P15428 5/20 0.41
MAPT P10636 4/20 0.41
ALDH1A1 P00352 6/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.38
HCRTR1 O43613 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775646 0.94 ABCB1 (0.42) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21774113 0.93 ABCB1 (0.43) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21775741 0.92 DGAT1 (0.43) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21775764 0.92 ABCB1 (0.44) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21749207 0.92 DGAT1 (0.43) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21775746 0.92 DGAT1 (0.43) ABCB1HPGDMAPTALDH1A1KMT2A
SCHEMBL21749150 0.89 ABCG2 (0.40) ABCB1HPGDMAPTALDH1A1NPC1
SCHEMBL21775744 0.89 ABCG2 (0.40) ABCB1HPGDMAPTALDH1A1NPC1
SCHEMBL21775864 0.89 ABCG2 (0.40) ABCB1HPGDMAPTALDH1A1NPC1
SCHEMBL21775681 0.86 ABCB1 (0.45) ABCB1HPGDMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 ABCB1 243/4885HPGD 1684/4885MAPT 2067/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 ABCB1 243/4885HPGD 1684/4885MAPT 2067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.